| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
Form 4: Valentine Keith, Director
Bought 35,000 shares ($243K) |
| 02 Nov 2026 |
Form 4: Demski David M, Director
Bought 60,000 shares ($409K) |
| 29 Oct 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Case volumes grew 20% and net new surgeon users increased 25% |
| 05 Oct 2026 |
Form 4: Carls Thomas Andrew, EVP, Data & Imaging Solutions
Received 200,000 shares as a grant or award |
| 24 Sep 2026 |
Form 3: Carls Thomas Andrew, EVP, Data & Imaging Solutions
Holds 2,520 shares of Common Stock |
| 10 Sep 2026 |
Form 4: Miles Patrick, Director
Bought 115,000 shares ($1.01M) |
| 07 Aug 2026 |
Form 4: Marshall Tyson Eliot, GENERAL COUNSEL & CORP. SEC.
Sold 8,168 shares ($78.8K) |
| 05 Aug 2026 | 144 |
| 04 Aug 2026 | 10-Q |
| 04 Aug 2026 | S-8 |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
Surgical revenue of $196 million increased 17%, driven by 20% case volume growth |
| 12 Jun 2026 |
Form 4: Mcginnis Karen K, Director
Received 32,012 shares as a grant or award · Sold 6,050 shares ($48.5K) |
| 12 Jun 2026 |
Form 4: Blackford Quentin S., Director
Received 32,012 shares as a grant or award |
| 12 Jun 2026 |
Form 4: Valentine Keith, Director
Received 32,012 shares as a grant or award |
| 12 Jun 2026 |
Form 4: Pelizzon David R, Director
Received 32,012 shares as a grant or award |
| 12 Jun 2026 |
Form 4: Demski David M, Director
Received 32,012 shares as a grant or award |
| 12 Jun 2026 |
Form 4: Berkowitz Mortimer Iii, Director
Received 32,012 shares as a grant or award |
| 11 Jun 2026 | S-8 |
| 11 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. ... |
Loading...